AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gebauer, S. K
Right arrow Articles by Kris-Etherton, P. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gebauer, S. K
Right arrow Articles by Kris-Etherton, P. M
Agricola
Right arrow Articles by Gebauer, S. K
Right arrow Articles by Kris-Etherton, P. M
American Journal of Clinical Nutrition, Vol. 83, No. 6, S1526-1535S, June 2006
© 2006 American Society for Nutrition


Supplement: n–3 Fatty Acids: Recommendations for Therapeutics and Prevention

n–3 Fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits1,2,3

Sarah K Gebauer, Tricia L Psota, William S Harris and Penny M Kris-Etherton

1 From the Department of Nutritional Sciences, Pennsylvania State University, University Park, PA (SKG, TLP, and PMK-E), and the Lipid and Diabetes Research Center, Saint Luke's Hospital, and the University of Missouri-Kansas City School of Medicine, Kansas City, MO (WSH)

ABSTRACT

Dietary recommendations have been made for n–3 fatty acids, including {alpha}-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) to achieve nutrient adequacy and to prevent and treat cardiovascular disease. These recommendations are based on a large body of evidence from epidemiologic and controlled clinical studies. The n–3 fatty acid recommendation to achieve nutritional adequacy, defined as the amount necessary to prevent deficiency symptoms, is 0.6–1.2% of energy for ALA; up to 10% of this can be provided by EPA or DHA. To achieve recommended ALA intakes, food sources including flaxseed and flaxseed oil, walnuts and walnut oil, and canola oil are recommended. The evidence base supports a dietary recommendation of {approx}500 mg/d of EPA and DHA for cardiovascular disease risk reduction. For treatment of existing cardiovascular disease, 1 g/d is recommended. These recommendations have been embraced by many health agencies worldwide. A dietary strategy for achieving the 500-mg/d recommendation is to consume 2 fish meals per week (preferably fatty fish). Foods enriched with EPA and DHA or fish oil supplements are a suitable alternate to achieve recommended intakes and may be necessary to achieve intakes of 1 g/d.

Key Words: Dietary recommendations • EPA • eicosapentaenoic acid • DHA • docosahexaenoic acid • cardiovascular disease • n–3 fatty acids • fish oil • fish intake







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The American Society for Nutrition